Skip to main content

Advertisement

Log in

Treatment outcomes of percutaneous radiofrequency ablation versus adrenalectomy for adrenal metastases: a retrospective comparative study

  • Original Article
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

Purpose

To retrospectively evaluate the clinical outcomes of percutaneous ultrasound (US)-guided radiofrequency ablation (RFA) in treatment of adrenal metastasis (AM), and to compare with adrenalectomy (Adx).

Methods

From June 2008 to August 2018, a total of 60 patients with AM treated at our hospital were retrospectively reviewed, of whom 29 treated by RFA (RFA group) and 31 by Adx (Adx group). The technical success, local tumor progression (LTP) and overall survival (OS) after the treatment were evaluated and compared.

Results

In RFA group, the first technical success was 72.4% and the second technical success was 86.2%. In Adx group, all the AMs were successfully resected. After 24.5 ± 19.1 months follow-up period, a total of 8 patients (6 in RFA group and 2 in Adx group) were detected LTP. The 1-, 2- and 3- LTP rates after treatment were 17.1%, 30.9% and 44.7% in RFA group, and 6.5%, 6.5% and 6.5% in Adx group, respectively (P = 0.028). However, for AM ≤ 5 cm, the LTP between the two groups were comparable (P = 0.068). The 1-, 2- and 3- OS rates after treatment for AM were 85.0%, 42.4% and 27.8% in RFA group, and 93.0%, 66.1% and 52.3% in Adx group, respectively (P = 0.057). RFA offered shorter treatment time (23.6 ± 16.9 vs. 155.6 ± 58.8 min, P < 0.001), shorter hospital stay (7.8 ± 3.9 vs. 15.0 ± 4.9 days, P < 0.001), and lower hospital cost ($3405.7 ± 1067.8 vs. $5248.0 ± 2261.3, P = 0.003) than Adx.

Conclusion

In comparison with Adx, percutaneous US-guided RFA, as an alternative treatment, is feasible and effective in controlling AM, especially in AM ≤ 5 cm in diameter.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Abrams HL, Spiro R, Goldstein N (1950) Metastases in carcinoma; analysis of 1000 autopsied cases. Cancer 3(1):74–85

    CAS  PubMed  Google Scholar 

  2. Milgrom SA, Goodman KA (2012) The role of radiation therapy in the management of adrenal carcinoma and adrenal metastases. J Surg Oncol 106(5):647–650

    PubMed  Google Scholar 

  3. Muth A, Persson F, Jansson S, Johanson V, Ahlman H, Wangberg B (2010) Prognostic factors for survival after surgery for adrenal metastasis. Eur J Surg Oncol 36(7):699–704

    CAS  PubMed  Google Scholar 

  4. Howell GM, Carty SE, Armstrong MJ et al (2013) Outcome and prognostic factors after adrenalectomy for patients with distant adrenal metastasis. Ann Surg Oncol 20(11):3491–3496

    PubMed  PubMed Central  Google Scholar 

  5. Hokotate H, Inoue H, Baba Y, Tsuchimochi S, Nakajo M (2003) Aldosteronomas: experience with superselective adrenal arterial embolization in 33 cases. Radiology 227(2):401–406

    PubMed  Google Scholar 

  6. Jiang CL, Liu BX, Chen SL, Peng ZW, Xie XY, Kuang M (2018) Safety margin after radiofrequency ablation of hepatocellular carcinoma: precise assessment with a three-dimensional reconstruction technique using CT imaging. Int J Hyperth 34(8):1135–1141

    CAS  Google Scholar 

  7. Johnson B, Sorokin I, Cadeddu JA (2019) Ten-year outcomes of renal tumor radio frequency ablation. J Urol 201:251–258

    PubMed  Google Scholar 

  8. Tomasian A, Jennings JW (2018) Spinal osteoid osteoma: percutaneous radiofrequency ablation using a navigational bipolar electrode system. Am J Roentgenol 211(4):856–860

    Google Scholar 

  9. Nunes TF, Szejnfeld D, Xavier AC et al (2013) Percutaneous ablation of functioning adrenal adenoma: a report on 11 cases and a review of the literature. Abdom Imaging 38(5):1130–1135

    PubMed  Google Scholar 

  10. Hasegawa T, Yamakado K, Nakatsuka A et al (2015) Unresectable adrenal metastases: clinical outcomes of radiofrequency ablation. Radiology 277(2):584–593

    PubMed  Google Scholar 

  11. Moreno P, de la Quintana BA, Musholt TJ et al (2013) Adrenalectomy for solid tumor metastases: results of a multicenter European study. Surgery 154(6):1215–1222

    PubMed  Google Scholar 

  12. Welch BT, Atwell TD, Nichols DA et al (2011) Percutaneous image-guided adrenal cryoablation: procedural considerations and technical success. Radiology 258(1):301–307

    PubMed  Google Scholar 

  13. Yang MH, Tyan YS, Huang YH, Wang SC, Chen SL (2016) Comparison of radiofrequency ablation versus laparoscopic adrenalectomy for benign aldosterone-producing adenoma. Radiol Med 121(10):811–819

    PubMed  Google Scholar 

  14. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–213

    PubMed  PubMed Central  Google Scholar 

  15. Omary RA, Bettmann MA, Cardella JF et al (2003) Quality improvement guidelines for the reporting and archiving of interventional radiology procedures. J Vasc Interv Radiol 14(9 Pt 2):S293–S295

    PubMed  Google Scholar 

  16. Welch BT, Callstrom MR, Carpenter PC et al (2014) A single-institution experience in image-guided thermal ablation of adrenal gland metastases. J Vasc Interv Radiol 25(4):593–598

    PubMed  Google Scholar 

  17. Frenk NE, Daye D, Tuncali K et al (2018) Local control and survival after image-guided percutaneous ablation of adrenal metastases. J Vasc Interv Radiol 29(2):276–284

    PubMed  Google Scholar 

  18. Huang J, Xie X, Lin J et al (2019) Percutaneous radiofrequency ablation of adrenal metastases from hepatocellular carcinoma: a single-center experience. Cancer Imaging 19(1):44

    PubMed  PubMed Central  Google Scholar 

  19. Fong Y, Cohen AM, Fortner JG et al (1997) Liver resection for colorectal metastases. J Clin Oncol 15(3):938–946

    CAS  PubMed  Google Scholar 

  20. Yamakado K, Takaki H, Yamada T et al (2012) Incidence and cause of hypertension during adrenal radiofrequency ablation. Cardiovasc Intervent Radiol 35(6):1422–1427

    PubMed  Google Scholar 

  21. Men M, Ye X, Fan W et al (2016) Short-term outcomes and safety of computed tomography-guided percutaneous microwave ablation of solitary adrenal metastasis from lung cancer: a multi-center retrospective study. Korean J Radiol 17(6):864–873

    PubMed  PubMed Central  Google Scholar 

  22. Otsuka H, Imai M, Kemmotsu O (1993) Hypertensive crisis during the resection of an adrenal tumor in primary aldosteronism. J Anesth 7(2):139–144

    CAS  PubMed  Google Scholar 

  23. Wolf FJ, Dupuy DE, Machan JT, Mayo-Smith WW (2012) Adrenal neoplasms: effectiveness and safety of CT-guided ablation of 23 tumors in 22 patients. Eur J Radiol 81(8):1717–1723

    PubMed  Google Scholar 

  24. Sarwar A, Brook OR, Vaidya A et al (2016) Clinical outcomes following percutaneous radiofrequency ablation of unilateral aldosterone-producing adenoma: comparison with adrenalectomy. J Vasc Interv Radiol 27(7):961–967

    PubMed  PubMed Central  Google Scholar 

  25. Lo WK, Vansonnenberg E, Shankar S et al (2006) Percutaneous CT-guided radiofrequency ablation of symptomatic bilateral adrenal metastases in a single session. J Vasc Interv Radiol 17(1):175–179

    PubMed  Google Scholar 

  26. Schlageter M, Quagliata L, Matter M, Perrina V, Tornillo L, Terracciano L (2016) Clinicopathological features and metastatic pattern of hepatocellular carcinoma: an autopsy study of 398 patients. Pathobiology 83(6):301–307

    PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported by the National Natural Science Foundation of China (Grant No. 81701708 and 81530055); Natural Science Foundation of Guangdong Province (Grant No. 2017A030310205); and Training Project for Young Teacher of Sun Yat-sen University (Grant No. 18ykpy10).

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to B. Liu or X. Xie.

Ethics declarations

Conflict of interest

The authors state that there is no conflict of interests in the publication of this paper.

Ethical approval

This retrospective study was carried out according to the guidelines of the Helsinki Declaration.

Research involving human participants and/or animals

The study was approved by the Ethical Committee of the First Affiliated Hospital of Sun Yat-sen University (Guangzhou, China).

Informed consent

All the patients signed an informed consent to be enrolled in the study and to perform the RFA procedure.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 23 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liu, B., Mo, C., Wang, W. et al. Treatment outcomes of percutaneous radiofrequency ablation versus adrenalectomy for adrenal metastases: a retrospective comparative study. J Endocrinol Invest 43, 1249–1257 (2020). https://doi.org/10.1007/s40618-020-01212-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40618-020-01212-w

Keywords

Navigation